Cementos Pacasmayo S.A.A (CPAC) Earnings Analysis
Cementos Pacasmayo S.A.A (CPAC) next reports earnings on 2026-10-27, consensus EPS 0.1534 USD. Last quarter (2026-07-20) it beat with EPS 0.26 USD vs 0.1152 USD est (+125.7%). It has beaten estimates in 4/6 recent quarters (67%). Trailing P/E 16.10.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CPAC next report earnings?
| Next earnings date | 2026-10-27 |
|---|---|
| Consensus EPS estimate | 0.1534 USD |
| Revenue estimate | 0.16B |
CPAC earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-07-20 | 0.26 USD | 0.1152 USD | +125.7% | Beat |
| 2026-04-24 | 0.28 USD | 0.1085 USD | +158.1% | Beat |
| 2026-02-12 | -0.06 USD | 0.05 USD | -220% | Miss |
| 2025-07-21 | 0.15 USD | 0.1 USD | +50% | Beat |
| 2025-04-28 | 0.16 USD | 0.14 USD | +14.3% | Beat |
| 2025-02-13 | 0.15 USD | 0.18 USD | -16.7% | Miss |
Beat rate: 4/6 (67%) over reported quarters with consensus data.
CPAC valuation and analyst view
| Trailing P/E | 16.10 |
|---|---|
| Trailing EPS | 2.487 USD |
| Price / book | 2.55 |
| Dividend yield | 5.12% |
| Market cap | 1.00B |
| Analyst consensus | Hold (2 buy / 6 hold / 0 sell) |
| Avg price target | 13 USD |
Related research pages
Frequently asked questions
When is Cementos Pacasmayo S.A.A (CPAC)'s next earnings date?
Cementos Pacasmayo S.A.A is next scheduled to report on 2026-10-27, with a consensus EPS estimate of 0.1534 USD and revenue estimate of 0.16B.
Did CPAC beat earnings last quarter?
In its 2026-07-20 report, CPAC posted EPS of 0.26 USD versus a 0.1152 USD estimate — a beat of 125.7%.
What is CPAC's earnings track record?
Over the last 6 reported quarters with consensus data, CPAC beat estimates 4 times (67%).
What is CPAC's current P/E ratio and EPS?
CPAC trades at a trailing P/E of 16.10 on trailing EPS of 2.4865279007350964 USD.
What do analysts rate CPAC?
Analyst consensus is "Hold" across 8 ratings (0 strong buy, 2 buy, 6 hold, 0 sell, 0 strong sell). Average 12-month price target: 13 USD.